Mixed Market, Solid Footing: Psomagen and Jetema Stand Out [K-Bio Pulse] 유진희 2026.07.02 오전 08:00 Korean Bio Stocks Diverge Amid Market Rally...Jetema and Genome Shine as "Value Gems" [... 유진희 2026.06.01 오전 08:00 Cellbion Reports Positive Phase 2 Results in Prostate Cancer Therapy 유진희 2025.09.04 오후 06:00 Geopolitical Risks Refocus Market on Undervalued Bio Gems...Woojung Bio·Geninus Surge[K-Bio Puls... 유진희 2026.03.09 오전 08:00 Investment Sentiment Shifts to Mid Risk...High Return Bio Stocks: Samyang Biopharm and U2Bio Surg... 유진희 2026.01.15 오전 08:10 GI Innovation and Orient Bio Surge on Strong Data and Governance [K-Bio Pulse] 유진희 2026.06.12 오전 08:00 Sellbion CEO Kwon Kim: “Maximizing the Power of 177Lu-DGUL Immuno-Oncology Combo” 유진희 2025.07.21 오전 09:30 Unsolved Hair Loss Seeking a Breakthrough?...FromBio and Hyundai Pharm Surge [K-Bio Pulse] 유진희 2026.01.19 오전 08:00 Cellbion’s radiotherapy shows 35% ORR, looks to expand Merck ties 유진희 2025.09.05 오전 08:30 Biopharma Earnings Drive Undervalued Stocks Higher, L&C Bio Extends Rally[K-Bio Pulse] 유진희 2025.09.09 오전 09:30 더 보기 로딩중..
phamedaily
phamedaily
![Mixed Market, Solid Footing: Psomagen and Jetema Stand Out [K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/07/PS26070200261b.jpg)
![GI Innovation and Orient Bio Surge on Strong Data and Governance [K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/06/PS26061200195b.jpg)
![Unsolved Hair Loss Seeking a Breakthrough?...FromBio and Hyundai Pharm Surge [K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/01/PS26011900132b.jpg)
![Biopharma Earnings Drive Undervalued Stocks Higher, L&C Bio Extends Rally[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/09/PS25091400101b.jpg)